← Back to headlines

FDA Renews Authorization for Philip Morris IQOS as Modified Risk Tobacco Product
The U.S. Food and Drug Administration (FDA) has renewed the authorization for Philip Morris International's IQOS as a Modified Risk Tobacco Product (MRTPA).
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.



